DSP Nifty Healthcare Index Fund

A Index Funds scheme from DSP Mutual Fund. Figures below are for the Direct · Growth plan (ISIN INF740KA1WF0).

NAV ₹12.2179 on 16 November 2026.

Expense ratio

Total expense ratio 0.40% a year for the Direct · Growth plan, as AMFI published it on 29 October 2026: base expense ratio 0.21%, brokerage 0.02%, transaction costs 0.00%, statutory levies including GST 0.17%.

Returns and risk

PeriodReturn a yearVolatilityWorst fallSharpeSortino
1 year15.9%14.5%-9.2%0.610.66

Too little NAV history for the 3, 5, 10-year figures.

Not ranked in its category: its category mixes funds too different to rank against one another.

Largest holdings

Top 10 (October 2026 disclosure). Company shares make up 100.0% of the portfolio.

  1. Sun Pharmaceutical Industries Limited — 16.32%
  2. Divi's Laboratories Limited — 10.78%
  3. Laurus Labs Limited — 8.12%
  4. Apollo Hospitals Enterprise Limited — 7.54%
  5. Dr. Reddy's Laboratories Limited — 7.15%
  6. Cipla Limited — 6.73%
  7. Torrent Pharmaceuticals Limited — 5.89%
  8. Max Healthcare Institute Limited — 5.55%
  9. Lupin Limited — 4.23%
  10. Aurobindo Pharma Limited — 4.03%

Plans

Other funds in Index Funds

All 275 funds in Index Funds · Compare this fund with another

Past returns are history, not a forecast. XIRRO describes funds and portfolios; it is information, not investment advice.